Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Company News
As of August 4, 2025 • 9:01 PM ET
Additional News
As of August 4, 2025 • 9:01 PM ET
| Date/Time | Source | News Release |
|---|---|---|
| 08/04/2025 06:00 PM EDT | SeekingAlpha | Here are the major earnings before the open Tuesday |
| 08/04/2025 11:31 AM EDT | SeekingAlpha | Iterum Therapeutics Q2 Earnings Preview |
| 05/13/2025 01:44 PM EDT | SeekingAlpha | Iterum targets ORLYNVAH US launch by Q4 2025 while extending cash runway into 2026 |
| 05/13/2025 01:44 PM EDT | SeekingAlpha | Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript |
| 05/13/2025 07:05 AM EDT | SeekingAlpha | Iterum Therapeutics Non-GAAP EPS of -$0.10 |
| 05/13/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Tuesday, May 13th, 2025 |
| 05/13/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - Iterum Therapeutics plc |
| 02/07/2025 04:40 PM EST | SeekingAlpha | Iterum Therapeutics files for $150M mixed securities shelf |
| 02/07/2025 10:20 AM EST | SeekingAlpha | Iterum outlines ORLYNVAH's market potential with exclusivity through 2034 |
| 02/07/2025 10:20 AM EST | SeekingAlpha | Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.